Loraz and Jadenu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Loraz (lorazepam) and Jadenu (deferasirox). Common drug interactions include arrhythmia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Loraz and Jadenu. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Loraz?

Loraz has active ingredients of lorazepam. It is often used in stress and anxiety. eHealthMe is studying from 165,694 Loraz users. Check the latest studies of Loraz.

What is Jadenu?

Jadenu has active ingredients of deferasirox. eHealthMe is studying from 4,176 Jadenu users. Check the latest studies of Jadenu.

On Jul, 10, 2026

29 people who take Loraz and Jadenu together, and have interactions are studied.

What are the common drug interactions of Loraz and Jadenu, by gender? *:

female:

Arrhythmia (irregular heartbeat)
Asthenia (weakness)
Confusional state
Lethargy (tiredness)
Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
Back pain
Diarrhoea
Nausea (feeling of having an urge to vomit)
Vomiting
Arthralgia (joint pain)

male:

Asthenia (weakness)
Fatigue (feeling of tiredness)
Chest pain
Connective tissue disorder (any disease that has the connective tissues of the body)
Gastrointestinal oedema (excessive build-up of fluid in the gastrointestinal tract tissues)
Haematocrit decreased
Lactate dehydrogenase urine increased
Malaise (a feeling of general discomfort or uneasiness)
Myelocyte count decreased (a young white blood cell found in the bone marrow decreased)
Nephropathy (damage to or disease of a kidney)

What are the common drug interactions of Loraz and Jadenu, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Hospitalisation

20-29:

Pancreatitis (inflammation of pancreas)

30-39:

Diarrhoea
Nausea (feeling of having an urge to vomit)
Vomiting

40-49:

Asthenia (weakness)
Dizziness
Fatigue (feeling of tiredness)
Diarrhoea

50-59:

n/a

60+:

Asthenia (weakness)
Arrhythmia (irregular heartbeat)
Connective tissue disorder (any disease that has the connective tissues of the body)
Fatigue (feeling of tiredness)
Gastrointestinal oedema (excessive build-up of fluid in the gastrointestinal tract tissues)
Haematocrit decreased
Haemoglobin decreased
Lactate dehydrogenase urine increased
Lethargy (tiredness)
Malaise (a feeling of general discomfort or uneasiness)

What are the existing conditions these people have? *

Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 13 people, 44.83%
Primary Myelofibrosis (primary disorder of the bone marrow): 10 people, 34.48%
Iron Overload: 4 people, 13.79%
Haemochromatosis (body to absorb more iron than usual from food): 4 people, 13.79%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 3 people, 10.34%
Oedema (fluid collection in tissue): 3 people, 10.34%
Neuropathy Peripheral (surface nerve damage): 3 people, 10.34%
Nausea And Vomiting: 3 people, 10.34%
Nausea (feeling of having an urge to vomit): 3 people, 10.34%
Injection Site Reaction: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Loraz and Jadenu?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously